Redefining what’s possible in precision medicine and transforming the landscape of cancer diagnostics
Client OverviewClient: PATHOMIQ AI
Industry: Healthcare AI
Location: Cupertino, California
Scope: Brand & Visual Identity, Website Design & Development, Brand Guidelines
01
Getting StartedAs a rapidly emerging leader in AI-driven diagnostics, PATHOMIQ AI required a complete rebrand that could clearly communicate scientific credibility, technological sophistication, and clinical impact—while remaining bold, modern, and approachable for a highly specialized audience. The brand also needed a scalable digital foundation to support product growth, thought leadership, and ongoing innovation.
02
Building the BrandWe led a comprehensive rebrand from the ground up, beginning with a detailed mood board to define the visual and emotional direction of the brand. The resulting identity balances confidence and clarity through a bold yet restrained palette of red, black, and cream—paired with genomic grid-inspired imagery that introduces structured square elements throughout the system.
The visual identity was designed to feel precise, intelligent, and future-forward, while remaining clean and intuitive across digital and print applications.
03
Web Planning & LaunchOnce the brand vision was established, we translated it into a fully realized digital experience. Our work included:
Logo design and brand mark system
Typography and color palette development
Comprehensive brand guidelines
Digital and print marketing templates
Website design and development
The website experience spans multiple key sections, including home, services, platform, team, about, publications, news, and contact—each thoughtfully designed to support storytelling, usability, and credibility within clinical and research environments.
Project Results
PATHOMIQ AI now has a cohesive, high-impact brand and digital presence that reflects the power and precision of its technology.
The site is currently in the process of going live, and we’re excited to see the brand fully come to life in 2026 as PATHOMIQ AI continues to shape the future of cancer diagnostics and precision medicine.